Ongoing mutations in the N-terminal domain of c-Myc affect transactivation in Burkitt's lymphoma cell lines.

scientific article published on March 1994

Ongoing mutations in the N-terminal domain of c-Myc affect transactivation in Burkitt's lymphoma cell lines. is …
instance of (P31):
scholarly articleQ13442814

External links are
P698PubMed publication ID8108117

P2093author name stringAlbert T
Eick D
Kohlhuber F
Hammersen B
Urlbauer B
P433issue3
P407language of work or nameEnglishQ1860
P921main subjectBurkitt lymphomaQ1016605
P304page(s)759-763
P577publication date1994-03-01
P1433published inOncogeneQ1568657
P1476titleOngoing mutations in the N-terminal domain of c-Myc affect transactivation in Burkitt's lymphoma cell lines
P478volume9

Reverse relations

described by source (P1343)
Q54585241380
Q54797102BL-12
Q54797119BL-18
Q54797123BL-21
Q54797148BL-37
Q54797238BL-67
Q54797246BL-72
Q102113626BL-78
Q54797261BL-9
Q54832991EW-12
Q54832998EW-2
Q54833003EW-7
Q54897123IARC-171
Q54897138IARC-309
Q102114182IARC-591
Q54898919JI
Q54898929Jiyoye
Q54903329Ly67
Q54903979Maku
Q54907095Mutu-1
Q54907132Mwika
Q54937282P3HR-1
Q54993790WeWak1

cites work (P2860)
Q36553239A link between increased transforming activity of lymphoma-derived MYC mutant alleles, their defective regulation by p107, and altered phosphorylation of the c-Myc transactivation domain
Q55481055A polymorphic variant of human c-Myc: Asn11-->Ser.
Q33797347Activated Notch1 modulates gene expression in B cells similarly to Epstein-Barr viral nuclear antigen 2.
Q35082715Balance of Yin and Yang: ubiquitylation-mediated regulation of p53 and c-Myc
Q37214654Burkitt's lymphoma-associated c-Myc mutations converge on a dramatically altered target gene response and implicate Nol5a/Nop56 in oncogenesis
Q39542337COP1 is a tumour suppressor that causes degradation of ETS transcription factors
Q37114599Cross-talk between GlcNAcylation and phosphorylation: roles in insulin resistance and glucose toxicity
Q33964663Disruption of Myc-tubulin interaction by hyperphosphorylation of c-Myc during mitosis or by constitutive hyperphosphorylation of mutant c-Myc in Burkitt's lymphoma
Q41063703Epstein-Barr virus nuclear antigen 2 is a transcriptional suppressor of the immunoglobulin mu gene: implications for the expression of the translocated c-myc gene in Burkitt's lymphoma cells.
Q41134120Erroneous class switching and false VDJ recombination: molecular dissection of t(8;14)/MYC-IGH translocations in Burkitt-type lymphoblastic leukemia/B-cell lymphoma
Q36142180Evasion of the p53 tumour surveillance network by tumour-derived MYC mutants
Q34331166Glycosylation of the c-Myc transactivation domain
Q36622715Immortalization and transformation of human mammary epithelial cells by a tumor-derived Myc mutant
Q33965061Induction of cell cycle progression and acceleration of apoptosis are two separable functions of c-Myc: transrepression correlates with acceleration of apoptosis
Q39717211Multiple phenotypes associated with Myc-induced transformation of chick embryo fibroblasts can be dissociated by a basic region mutation
Q38568550Myc: the beauty and the beast
Q33625265O-linked beta-N-acetylglucosamine (O-GlcNAc): Extensive crosstalk with phosphorylation to regulate signaling and transcription in response to nutrients and stress
Q33742040Point Mutations in c-Myc Uncouple Neoplastic Transformation from Multiple Other Phenotypes in Rat Fibroblasts
Q35018846Targeting c-MYC with T-cells
Q33963949The c-Myc transactivation domain is a direct modulator of apoptotic versus proliferative signals
Q33962550c-Myc proteolysis by the ubiquitin-proteasome pathway: stabilization of c-Myc in Burkitt's lymphoma cells
Q39576244myc boxes, which are conserved in myc family proteins, are signals for protein degradation via the proteasome

Search more.